These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6489695)

  • 1. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
    Mukerji SK; Pimstone NR; Burns M
    Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
    Mukerji SK; Pimstone NR
    Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
    Blekkenhorst GH; Eales L; Pimstone NR
    S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
    Kushner JP; Steinmuller DP; Lee GR
    J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
    Elder GH; Lee GB; Tovey JA
    N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
    Mukerji SK; Pimstone NR; Tan KT
    FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The porphyria cutanea tarda group: their role among the enzyme defects of heme biosynthesis].
    Adrien A; Guillet G
    Sem Hop; 1984 Apr; 60(16):1148-52. PubMed ID: 6326308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
    Kushner JP
    Acta Derm Venereol Suppl (Stockh); 1982; 100():51-6. PubMed ID: 6962633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda.
    Sassa S; de Verneuil H; Anderson KE; Kappas A
    Trans Assoc Am Physicians; 1983; 96():65-75. PubMed ID: 6437037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
    Elder GH; Urquhart AJ
    IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enzymatic defect in porphyria cutanea tarda.
    Kushner JP
    N Engl J Med; 1982 Apr; 306(13):799-800. PubMed ID: 7062954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)].
    von Tiepermann R; Doss M
    J Clin Chem Clin Biochem; 1978 Sep; 16(9):513-7. PubMed ID: 712342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria.
    De Verneuil H; Sassa S; Kappas A
    Biochem J; 1983 Jul; 214(1):145-51. PubMed ID: 6412692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic haem metabolism in porphyria cutanea tarda (PCT): enzymatic studies and their relation to liver ultrastructure.
    Blekkenhorst GH; Pimstone NR; Webber BL; Eales L
    Ann Clin Res; 1976; 8 Suppl 17():108-21. PubMed ID: 1008481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental porphyria induced by chlorinated hydrocarbons. Studies of porphyrinogen carboxy-lyase in the experimental model of human cutaneous delayed porphyria].
    Ríos de Molina MC; Billi SC; Wainstok de Calmanovici R; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):393-407. PubMed ID: 6242264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda].
    Kondo M
    Nihon Hifuka Gakkai Zasshi; 1985 Aug; 95(9):995-6. PubMed ID: 4079084
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
    Franklin MR; Phillips JD; Kushner JP
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.